These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7966729)

  • 1. Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection.
    Uehling DT; Hopkins WJ; Dahmer LA; Balish E
    J Urol; 1994 Dec; 152(6 Pt 2):2308-11. PubMed ID: 7966729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
    Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
    J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.
    Uehling DT; Hopkins WJ; Balish E; Xing Y; Heisey DM
    J Urol; 1997 Jun; 157(6):2049-52. PubMed ID: 9146577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal immunization of monkeys against urinary tract infection with a multi-strain vaccine.
    Uehling DT; Hopkins WJ; James LJ; Balish E
    J Urol; 1994 Jan; 151(1):214-6. PubMed ID: 8254817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against urinary tract infection with a multi-valent vaginal vaccine.
    Uehling DT; James LJ; Hopkins WJ; Balish E
    J Urol; 1991 Jul; 146(1):223-6. PubMed ID: 2056594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal immunization against induced cystitis in monkeys.
    Uehling DT; Hopkins WJ; Jensen J; Balish E
    J Urol; 1987 Feb; 137(2):327-9. PubMed ID: 3543412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.
    Uehling DT; Hopkins WJ; Elkahwaji JE; Schmidt DM; Leverson GE
    J Urol; 2003 Sep; 170(3):867-9. PubMed ID: 12913718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial.
    Uehling DT; Hopkins WJ; Beierle LM; Kryger JV; Heisey DM
    J Infect Dis; 2001 Mar; 183 Suppl 1():S81-3. PubMed ID: 11171022
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased immunologic responsiveness following intensified vaginal immunization against urinary tract infection.
    Uehling DT; Hopkins WJ; Balish E
    J Urol; 1990 Jan; 143(1):143-5. PubMed ID: 2403596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular Immunization Induces Antigen-specific Antibodies in Urine.
    Derré L; Lucca I; Cesson V; Valerio M; Cerantola Y; Burruni R; Fritschi U; Gharbi D; Bobst M; Legris AS; Dartiguenave F; Jichlinski P; Nardelli-Haefliger D
    Eur Urol Focus; 2020 Mar; 6(2):280-283. PubMed ID: 30219710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.
    Eriksen B
    Am J Obstet Gynecol; 1999 May; 180(5):1072-9. PubMed ID: 10329858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immune response in the urinary tract of the rat following vaginal immunization.
    Jensen J; Uehling DT; Kim K; Seagren-Rasmussen K; Balish E
    J Urol; 1984 Jul; 132(1):164-6. PubMed ID: 6374173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
    Raz R; Stamm WE
    N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization against urinary tract infections.
    Uehling DT; Jensen J; Balish E
    J Urol (Paris); 1985; 91(1):23-6. PubMed ID: 3900224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal immunization against urinary tract infection.
    Uehling DT; Jensen J; Balish E
    J Urol; 1982 Dec; 128(6):1382-4. PubMed ID: 6759690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of human leucocyte antigen phenotype with vaccine efficacy in patients receiving vaginal mucosal immunization for recurrent urinary tract infection.
    Hopkins WJ; Heisey DM; Uehling DT
    Vaccine; 1999 Jan; 17(2):169-71. PubMed ID: 9987151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of IgA and IgG antibodies in vaginal fluid, serum and saliva following immunization of genital and gut associated lymphoid tissue.
    Bergmeier LA; Tao L; Gearing AJ; Adams S; Lehner T
    Adv Exp Med Biol; 1995; 371B():1567-73. PubMed ID: 7502858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.